Standard Operating Procedure for Horizon Scanning in Regulatory Affairs

Department	Regulatory Affairs
SOP No.	RA/2026/629
Supersedes	NA
Page No.	1 of X
Issue Date	08/04/2026
Effective Date	08/04/2026
Review Date	08/04/2028

Purpose

This Standard Operating Procedure (SOP) defines the systematic approach for horizon scanning activities within Regulatory Affairs to identify, assess, and monitor emerging regulatory trends, policies, and changes that can impact compliance and strategic decision-making. The objective is to ensure timely awareness and preparedness for regulatory developments that influence product registration, submission management, and overall regulatory compliance across all functional areas.

Scope

This SOP applies to all Regulatory Affairs personnel engaged in intelligence gathering, risk assessment, and policy monitoring related to domestic and international regulatory frameworks. It covers regulatory guidelines, legislative changes, public consultations, and technology advancements relevant to pharmaceuticals, biotechnology, medical devices, and healthcare products. Activities excluded from this SOP include routine document control and standard operating procedures unrelated to horizon scanning.

Responsibilities

The following roles are involved in the horizon scanning process:
– Regulatory Affairs Analysts: Execute scanning, data collection, and preliminary assessment.
– Regulatory Affairs Specialists: Review, validate, and provide technical interpretation of identified regulatory changes.
– Regulatory Affairs Managers: Oversee the process, facilitate communication, and ensure integration into existing workflows.
– Quality Assurance: Verify compliance of horizon scanning outputs with quality management system requirements.
– Document Control: Maintain and archive horizon scanning records and reports in compliance with GMP documentation standards.

Accountability

The Head of Regulatory Affairs is accountable for the implementation, periodic review, compliance monitoring, escalation of critical regulatory findings, and maintaining the effectiveness of the horizon scanning process. This role ensures resources are appropriately allocated and that the SOP remains aligned with evolving regulatory and business requirements.

Procedure

1. Preparation:
– Ensure all personnel involved have access to updated regulatory databases, newsletters, official websites, and authorized information sources.
– Set up monitoring tools and subscriptions aligned with regulatory regions and product categories relevant to the organization.

2. Prerequisites:
– Confirm training and understanding of horizon scanning objectives and relevant regulatory frameworks among team members.
– Verify availability of templates, checklists, and reporting formats specific to horizon scanning outputs.

3. Execution Steps:
– Conduct systematic scanning of identified sources on a defined schedule (e.g., weekly or monthly).
– Collect data on newly issued regulations, guidance documents, policy drafts, public consultations, and industry alerts.
– Screen and categorize information based on relevance, impact, and urgency.

4. In-Process Controls:
– Validate information accuracy and source authenticity.
– Cross-reference findings with internal compliance and operational teams for preliminary impact assessment.
– Record all findings using predefined templates.

5. Verification and Review:
– Regulatory Specialists review and interpret the significance of each finding.
– Summarize and prepare horizon scanning reports highlighting potential regulatory changes and recommended actions.

6. Acceptance Criteria:
– Reports must be complete, accurate, and submitted within established timelines.
– Identified regulatory changes should be actionable or flagged for further evaluation.

7. Handling Deviations:
– Document any missed updates, delays, or inaccuracies with corrective and preventive actions.
– Escalate critical deviations to the Head of Regulatory Affairs immediately.

8. Approvals:
– Obtain managerial approval of horizon scanning reports prior to dissemination.

9. Documentation and Record Retention:
– Store all reports, source lists, and related correspondence in designated document management systems.
– Retain records in accordance with organizational policies and regulatory expectations.

10. Closure:
– Communicate key findings to affected departments and facilitate integration with regulatory submission planning.
– Schedule periodic reviews to update scanning sources and revise the procedure as needed.

This procedure ensures continuous, proactive monitoring of regulatory environments critical to maintaining compliance, mitigating risks, and supporting strategic foresight in Regulatory Affairs.

Abbreviations

GMP – Good Manufacturing Practice
SOP – Standard Operating Procedure
RA – Regulatory Affairs
QA – Quality Assurance
API – Active Pharmaceutical Ingredient

Documents

The following documents are required to support the horizon scanning activities:

1. Horizon Scanning Report Template (Annexure-1)
2. Regulatory Source Monitoring Checklist (Annexure-2)
3. Deviation Report Form for Horizon Scanning (Annexure-3)

References

– International Conference on Harmonisation (ICH) Guidelines
– FDA Title 21 Code of Federal Regulations (CFR)
– EMA Regulatory Documents and Guidance
– Internal Quality Management System Documentation
– Good Manufacturing Practice Guidelines
– Organizational policies on regulatory compliance and documentation control

Version

1.0

Approval

Prepared By
Checked By
Approved By

Annexures

Annexure-1: Horizon Scanning Report Template

Purpose: To document and communicate the findings of regulatory horizon scanning activities, detailing identified changes, their impact, and recommended actions.

Report ID	HS-2026-0045
Date of Report	01/04/2026
Scanning Period	25/03/2026 – 31/03/2026
Prepared By
Reviewed By
Approved By

Summary of Findings:

Regulatory Area	Description	Source	Expected Impact	Recommended Action
Pharmaceuticals	Proposed update to API impurity limits in draft guideline.	EMA Draft Guideline, 28/03/2026	Moderate impact on quality testing requirements.	Review existing API specifications and prepare for update.
Medical Devices	New labeling requirements proposed for combination products.	FDA Federal Register, 30/03/2026	Potential design and documentation changes needed.	Alert product development and labeling departments.

Additional Notes:

Continue monitoring final publication status and allow for cross-functional impact assessments.

Annexure-2: Regulatory Source Monitoring Checklist

Purpose: To systematically verify that all relevant regulatory sources are monitored regularly for new or updated information.

Source Name	URL/Access Method	Frequency	Last Checked Date	Checked By	Remarks
EMA Website	https://www.ema.europa.eu	Weekly	31/03/2026		No new updates
FDA Federal Register	https://www.federalregister.gov	Twice Weekly	30/03/2026		Review draft guidances
ICH Website	https://www.ich.org	Monthly	01/03/2026		Upcoming guideline revisions

Annexure-3: Deviation Report Form for Horizon Scanning

Purpose: To report and document any deviations or failures in the horizon scanning process and corrective measures taken to prevent recurrence.

Deviation No.	DEV-HS-2026-001
Date Identified	02/04/2026
Reported By
Description of Deviation	Missed scheduled scan of FDA updates on 28/03/2026 resulting in delayed information dissemination.
Immediate Actions Taken	Conducted ad-hoc scan and notified impacted stakeholders.
Root Cause Analysis	Resource unavailability due to unforeseen absence.
Corrective Actions	Reassign scanning duties during absences and implement backup alert system.
Preventive Actions	Establish cross-training and escalation procedures.
Reviewed By
Approved By

Revision History

Revision Date	Revision No.	Revision Details	Reason for Revision	Approved By
08/04/2026	1.0	Initial issue	New SOP creation